| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.13 | 0.4 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |